152 related articles for article (PubMed ID: 34708678)
1. Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix.
Chen Y; Li S; Zhao J; Cao X; Wang F
J Drug Target; 2022 Mar; 30(3):326-333. PubMed ID: 34708678
[TBL] [Abstract][Full Text] [Related]
2. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.
Cao XW; Yang XZ; Du X; Fu LY; Zhang TZ; Shan HW; Zhao J; Wang FJ
J Drug Target; 2018 Nov; 26(9):777-792. PubMed ID: 29303375
[TBL] [Abstract][Full Text] [Related]
3. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
[TBL] [Abstract][Full Text] [Related]
5. Screening and characterisation of a novel efficient tumour cell-targeting peptide derived from insulin-like growth factor binding proteins.
He ML; Lei J; Cao XW; Zhao J; Wang FJ
J Drug Target; 2023 Jun; 31(5):500-510. PubMed ID: 36974745
[TBL] [Abstract][Full Text] [Related]
6. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
8. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
Elife; 2021 Oct; 10():. PubMed ID: 34713805
[TBL] [Abstract][Full Text] [Related]
9. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
Kardani K; Bolhassani A
PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823
[TBL] [Abstract][Full Text] [Related]
10. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
11. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Min S; Kim K; Ku S; Park JY; Seo J; Roh S
Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
[TBL] [Abstract][Full Text] [Related]
12. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
13. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
Ye J; Shin MC; Liang Q; He H; Yang VC
J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
[TBL] [Abstract][Full Text] [Related]
14. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
15. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
16. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
17. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
Xiang Y; Shan W; Huang Y
Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
[TBL] [Abstract][Full Text] [Related]
18. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
[TBL] [Abstract][Full Text] [Related]
19. Studies of proteoglycan involvement in CPP-mediated delivery.
Wittrup A; Zhang SH; Belting M
Methods Mol Biol; 2011; 683():99-115. PubMed ID: 21053125
[TBL] [Abstract][Full Text] [Related]
20. OBP fused with cell-penetrating peptides promotes liposomal transduction.
Gonçalves F; Castro TG; Nogueira E; Pires R; Silva C; Ribeiro A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2018 Jan; 161():645-653. PubMed ID: 29169119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
